Anal Cancer: Current and Future Methodology
- 1 January 2006
- journal article
- review article
- Published by Taylor & Francis Ltd in Cancer Investigation
- Vol. 24 (5), 535-544
- https://doi.org/10.1080/07357900600815208
Abstract
Despite the small number of patients affected by carcinoma of the anal canal it remains one of the most challenging cancers to treat. For although it is one of the few malignancies that may be cured with chemoradiation alone, the use of combined modality therapy may result in significant treatment-related morbidity. Novel approaches currently are underway in this select patient population and will be addressed for the purposes of this manuscript.Keywords
This publication has 53 references indexed in Scilit:
- Anal Carcinomas in HIV-Positive Patients: High-Dose Chemoradiotherapy Is Feasible in the Era of Highly Active Antiretroviral TherapyDiseases of the Colon & Rectum, 2005
- The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinicSexually Transmitted Infections, 2005
- Molecular biology of squamous cell carcinoma of the anus: a comparison of HIV-positive and HIV-negative patientsJournal of Gastrointestinal Surgery, 2004
- Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppressionTransplant International, 2004
- Squamous cell carcinoma of the anal marginJournal of Surgical Oncology, 2004
- Cisplatin-based combined modality therapy for anal carcinomaCancer, 2003
- Endoanal Ultrasound in the Staging and Management of Squamous-Cell Carcinoma of the Anal CanalDiseases of the Colon & Rectum, 2002
- Colposcopic appearance of anal squamous intraepithelial lesionsDiseases of the Colon & Rectum, 1997
- Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycinThe Lancet, 1996
- Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An eastern cooperative oncology group studyInternational Journal of Radiation Oncology*Biology*Physics, 1996